scholarly article | Q13442814 |
P50 | author | Giacomo Zanus | Q95630401 |
Davide Francesco D'Amico | Q117812114 | ||
P2093 | author name string | Mario Plebani | |
Alessandro Vitale | |||
Daniela Basso | |||
Filippo Navaglia | |||
Umberto Cillo | |||
Vito De Pascale | |||
Umberto Montin | |||
Alberto Brolese | |||
Francesco Antonio Ciarleglio | |||
Francesco D'Amico | |||
Marco Bassanello | |||
P2860 | cites work | Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma | Q24540058 |
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver | Q29616866 | ||
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis | Q29619508 | ||
Prognosis of hepatocellular carcinoma: the BCLC staging classification | Q29619984 | ||
Transection of the oesophagus for bleeding oesophageal varices | Q34211834 | ||
Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis | Q34515064 | ||
Prognostic prediction and treatment strategy in hepatocellular carcinoma. | Q34547469 | ||
Hepatocellular carcinoma: diagnosis and treatment | Q34642891 | ||
The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
Does surgical resection of hepatocellular carcinoma accelerate cancer dissemination? | Q36474581 | ||
Is surgery for large hepatocellular carcinoma justified? | Q39225087 | ||
Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma. | Q40525257 | ||
alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study | Q40650650 | ||
Predictive factors for intrahepatic recurrence after percutaneous ethanol injection therapy for small hepatocellular carcinoma | Q40780779 | ||
Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence | Q44391422 | ||
Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients | Q44498208 | ||
Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma | Q44759503 | ||
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival | Q46743120 | ||
Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma. | Q53318354 | ||
Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. | Q53350866 | ||
Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer | Q62658373 | ||
Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma | Q71660134 | ||
Prognosis after hepatic resection for stage IVA hepatocellular carcinoma: a need for reclassification | Q73076619 | ||
Hematogenous spreading of hepatocellular carcinoma cells: possible participation in recurrence in the liver | Q73107790 | ||
Prospective evaluation of circulating hepatocytes by alpha-fetoprotein mRNA in humans during liver surgery | Q73554970 | ||
Postoperative detection of alpha-fetoprotein mRNA in blood as a predictor for metastatic recurrence of hepatocellular carcinoma | Q73883818 | ||
Simplified staging for hepatocellular carcinoma | Q77768599 | ||
Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation | Q78052589 | ||
Presence of alpha-fetoprotein mRNA in blood correlates with outcome in patients with hepatocellular carcinoma | Q78147884 | ||
Multimodal approach and its impact on survival for patients with hepatocellular carcinoma | Q79357788 | ||
The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? | Q79363825 | ||
P433 | issue | 44 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 6920-6925 | |
P577 | publication date | 2005-11-01 | |
P1433 | published in | World Journal of Gastroenterology | Q15708885 |
P1476 | title | Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma | |
P478 | volume | 11 |
Q46134336 | 18F-FDG-uptake of hepatocellular carcinoma on PET predicts microvascular tumor invasion in liver transplant patients |
Q42172338 | A score model for predicting post-liver transplantation survival in HBV cirrhosis-related hepatocellular carcinoma recipients: a single center 5-year experience. |
Q36082480 | Alpha-fetoprotein and novel tumor biomarkers as predictors of hepatocellular carcinoma recurrence after surgery: a brilliant star raises again |
Q57792485 | Combination of biological and morphological parameters for the selection of patients with hepatocellular carcinoma waiting for liver transplantation |
Q50851803 | Comparison of Salvage Living Donor Liver Transplantation and Local Regional Therapy for Recurrent Hepatocellular Carcinoma. |
Q34017735 | Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies |
Q30416480 | Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort |
Q26772329 | Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation |
Q64091719 | Role of Allelic Imbalance in Predicting Hepatocellular Carcinoma (HCC) Recurrence Risk After Liver Transplant |
Q37876380 | Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation |